Pasar al contenido principal

APROXIMACIONES BASADAS EN LA FISIOLOGIA Y LA EVOLUCION PARA CONTRARRESTAR LA RESISTENCIA A LOS ANTIBIOTICOS

PID2020-113521RB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2020
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Efflux in Gram-negative bacteria: what are the latest opportunities for drug discovery?

  • Gil-Gil, Teresa
  • Laborda, Pablo
  • Ochoa-Sánchez, Luz-Edith
  • Hernando-Amado, Sara
  • Martínez Menéndez, José Luis
The resistance-nodulation-division (RND) family is the most important group of multidrug efflux pumps in Gram-negative bacteria. Their inhibition increases the susceptibility of these microorganisms to antibiotics. The study of the effect of efflux pumps' overexpression on bacterial physiology in antibiotic-resistant mutants allows for the identification of exploitable weaknesses associated with resistance acquisition., The authors are supported by the Ministerio de Ciencia e Innovación/Agencia Estatal de Investigación (MCIN/AEI) 10.13039/501100011033 through grant and the “Severo Ochoa” Programme for Centres of Excellence in R&D (SEV-2017-0712). T Gil-Gil is the recipient of a pre-doctoral FPI fellowship from the Ministry of Economy and Competitiveness (MINECO), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Translating eco-evolutionary biology into therapy to tackle antibiotic resistance

  • Sanz-García, Fernando
  • Gil-Gil, Teresa
  • Laborda, Pablo
  • Blanco, Paula
  • Ochoa-Sánchez, Luz-Edith
  • Baquero, Fernando
  • Martínez Menéndez, José Luis
  • Hernando-Amado, Sara
Antibiotic resistance is currently one of the most important public health problems. The golden age of antibiotic discovery ended decades ago, and new approaches are urgently needed. Therefore, preserving the efficacy of the antibiotics currently in use and developing compounds and strategies that specifically target antibiotic-resistant pathogens is critical. The identification of robust trends of antibiotic resistance evolution and of its associated trade-offs, such as collateral sensitivity or fitness costs, is invaluable for the design of rational evolution-based, ecology-based treatment approaches. In this Review, we discuss these evolutionary trade-offs and how such knowledge can aid in informing combination or alternating antibiotic therapies against bacterial infections. In addition, we discuss how targeting bacterial metabolism can enhance drug activity and impair antibiotic resistance evolution. Finally, we explore how an improved understanding of the original physiological function of antibiotic resistance determinants, which have evolved to reach clinical resistance after a process of historical contingency, may help to tackle antibiotic resistance., Work in the authors’ laboratories was supported by Ministerio de Ciencia e Innovación (MCIN), Agencia Estatal de Investigación (AEI) MCIN/AEI/10.13039/501100011033 grant PID2020-113521RB-I00. T.G.-G. is recipient of a Formación de Personal Investigador fellowship from Ministerio de Economía y Competitividad., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Role of bacterial multidrug efflux pumps during infection

  • Laborda, Pablo
  • Molin, Søren
  • Johansen, Helle Krogh
  • Martínez Menéndez, José Luis
  • Hernando-Amado, Sara
Multidrug efflux pumps are protein complexes located in the cell envelope that enable bacteria to expel, not only antibiotics, but also a wide array of molecules relevant for infection. Hence, they are important players in microbial pathogenesis. On the one hand, efflux pumps can extrude exogenous compounds, including host-produced antimicrobial molecules. Through this extrusion, pathogens can resist antimicrobial agents and evade host defenses. On the other hand, efflux pumps also have a role in the extrusion of endogenous compounds, such as bacterial intercommunication signaling molecules, virulence factors or metabolites. Therefore, efflux pumps are involved in the modulation of bacterial behavior and virulence, as well as in the maintenance of the bacterial homeostasis under different stresses found within the host. This review delves into the multifaceted roles that efflux pumps have, shedding light on their impact on bacterial virulence and their contribution to bacterial infection. These observations suggest that strategies targeting bacterial efflux pumps could both reinvigorate the efficacy of existing antibiotics and modulate the bacterial pathogenicity to the host. Thus, a comprehensive understanding of bacterial efflux pumps can be pivotal for the development of new effective strategies for the management of infectious diseases., Work in JLM laboratory is supported by the Ministerio de Ciencia e Innovación/Agencia Estatal de Inves- tigación (MCIN/AEI) 10.13039/501100011033 through grant PID2020-113521RB-I00. Work in HKJ laboratory is supported by The Novo Nordisk Foundation (NNF) Challenge grant NNF19OC0056411 and a grant from THE JOHN AND BIRTHE MEYER FOUNDATION (2022)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Preserving the efficacy of antibiotics to tackle antibiotic resistance

  • Laborda, Pablo
  • Gil-Gil, Teresa
  • Martínez Menéndez, José Luis
  • Hernando-Amado, Sara
Different international agencies recognize that antibiotic resistance is one of the most severe human health problems that humankind is facing. Traditionally, the introduction of new antibiotics solved this problem but various scientific and economic reasons have led to a shortage of novel antibiotics at the pipeline. This situation makes mandatory the implementation of approaches to preserve the efficacy of current antibiotics. The concept is not novel, but the only action taken for such preservation had been the 'prudent' use of antibiotics, trying to reduce the selection pressure by reducing the amount of antibiotics. However, even if antibiotics are used only when needed, this will be insufficient because resistance is the inescapable outcome of antibiotics' use. A deeper understanding of the alterations in the bacterial physiology upon acquisition of resistance and during infection will help to design improved strategies to treat bacterial infections. In this article, we discuss the interconnection between antibiotic resistance (and antibiotic activity) and bacterial metabolism, particularly in vivo, when bacteria are causing infection. We discuss as well how understanding evolutionary trade-offs, as collateral sensitivity, associated with the acquisition of resistance may help to define evolution-based therapeutic strategies to fight antibiotic resistance and to preserve currently used antibiotics., The laboratory of JLM is supported by MCIN/AEI/10.13039/501100011033, grant PID2020-­113521RB-­I00., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Use of adjuvants to improve antibiotic efficacy and reduce the burden of antimicrobial resistance

  • Gil-Gil, Teresa
  • Laborda, Pablo
  • Martínez Menéndez, José Luis
  • Hernando-Amado, Sara
The increase in antibiotic resistance, together with the absence of novel antibiotics, makes mandatory the introduction of novel strategies to optimize the use of existing antibiotics. Among these strategies, the use of molecules that increase their activity looks promising., JL Martínez and S Hernando-Amado are supported by the Ministerio de Ciencia e Innovación/Agencia Estatal de Investigación (MCIN/AEI) 10.13039/501100011033, respectively, through grants PID2020-113521RB-I00 and PID2023-149913OA-I00., Peer reviewed